Literature DB >> 10329477

Marburg's variant of multiple sclerosis correlates with a less compact structure of myelin basic protein.

D R Beniac1, D D Wood, N Palaniyar, F P Ottensmeyer, M A Moscarello, G Harauz.   

Abstract

Multiple sclerosis (MS) is an autoimmune disease in which the myelin sheath of the central nervous system is degraded, and the 18.5 kDa isoform of myelin basic protein (MBP) is reduced in cationicity. In a unique case of acute, fulminating MS (Marburg's variant), MBP is considerably less cationic than MBP from both normal, and chronic MS-afflicted individuals. This electron microscopical study has identified that, in vitro, the less cationic Marburg MBP isomer forms a more extended protein-lipid complex than MBP from healthy or chronic MS-afflicted individuals. This correlation implies that chemical modifications to MBP in vivo contribute directly to the structural instability of myelin, and subsequent autoantigenic presentation of this protein, observed in vivo in MS.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10329477     DOI: 10.1006/mcbr.1999.0111

Source DB:  PubMed          Journal:  Mol Cell Biol Res Commun        ISSN: 1522-4724


  11 in total

Review 1.  Peptidylarginine deiminase and protein citrullination in prion diseases: strong evidence of neurodegeneration.

Authors:  Byungki Jang; Akihito Ishigami; Naoki Maruyama; Richard I Carp; Yong-Sun Kim; Eun-Kyoung Choi
Journal:  Prion       Date:  2012-09-28       Impact factor: 3.931

2.  Occurrence and long-term outcome of tumefactive demyelinating lesions in multiple sclerosis.

Authors:  Rocco Totaro; C Di Carmine; A Splendiani; S Torlone; L Patriarca; C Carrocci; S Sciamanna; C Marini; A Carolei
Journal:  Neurol Sci       Date:  2016-04-15       Impact factor: 3.307

Review 3.  A tale of two citrullines--structural and functional aspects of myelin basic protein deimination in health and disease.

Authors:  George Harauz; Abdiwahab A Musse
Journal:  Neurochem Res       Date:  2006-08-09       Impact factor: 3.996

Review 4.  Analogous structural motifs in myelin basic protein and in MARCKS.

Authors:  G Harauz; N Ishiyama; I R Bates
Journal:  Mol Cell Biochem       Date:  2000-06       Impact factor: 3.396

5.  Role of Helical Structure in MBP Immunodominant Peptides for Efficient IgM Antibody Recognition in Multiple Sclerosis.

Authors:  Agnieszka Staśkiewicz; Michael Quagliata; Feliciana Real-Fernandez; Francesca Nuti; Roberta Lanzillo; Vincenzo Brescia-Morra; Hendrik Rusche; Michal Jewginski; Alfonso Carotenuto; Diego Brancaccio; Rina Aharoni; Ruth Arnon; Paolo Rovero; Rafal Latajka; Anna Maria Papini
Journal:  Front Chem       Date:  2022-06-20       Impact factor: 5.545

Review 6.  Tumefactive Demyelinating Lesions in Multiple Sclerosis and Associated Disorders.

Authors:  Meredith C Frederick; Michelle H Cameron
Journal:  Curr Neurol Neurosci Rep       Date:  2016-03       Impact factor: 5.081

7.  Membrane Association Landscape of Myelin Basic Protein Portrays Formation of the Myelin Major Dense Line.

Authors:  Arne Raasakka; Salla Ruskamo; Julia Kowal; Robert Barker; Anne Baumann; Anne Martel; Jussi Tuusa; Matti Myllykoski; Jochen Bürck; Anne S Ulrich; Henning Stahlberg; Petri Kursula
Journal:  Sci Rep       Date:  2017-07-10       Impact factor: 4.379

8.  A Case of Marburg's Variant of Multiple Sclerosis Successfully Treated with IVIg and Mitoxantrone.

Authors:  Adarsh Manuel; Madabhushi Chakravarthy Vasudevan
Journal:  Ann Indian Acad Neurol       Date:  2021-02-16       Impact factor: 1.383

9.  Marburg Multiple Sclerosis Variant: Complete Remission with Very Early Administration of Mitoxantrone-A Case Report.

Authors:  Nicolas Capet; Michael Levraut; Adrien Delourme; Oceane Thomel-Rocchi; Véronique Bourg; Philippe Cabre; Fanny Vandenbos; Lydiane Mondot; Christine Lebrun-Frenay
Journal:  Neurol Ther       Date:  2021-12-02

Review 10.  Flexible Players within the Sheaths: The Intrinsically Disordered Proteins of Myelin in Health and Disease.

Authors:  Arne Raasakka; Petri Kursula
Journal:  Cells       Date:  2020-02-18       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.